GLMD Galmed Pharmaceuticals Ltd: Rasio nilai perusahaan marang pendapatan

Logo perusahaan publik Galmed Pharmaceuticals (GLMD)

The EV/Sales history demonstrates how the market values Galmed Pharmaceuticals (GLMD), which implements advanced therapies for metabolic liver disorders. The parameter reaches 0.00, while the company adheres to environmental regulations when working with laboratory reagents. The business's fundamental potential relies on small molecule synthesis and large-scale trials of the drug Aramchol to combat chronic pathologies.

Multiplikator EV/Sales Galmed Pharma (GLMD): kanggo periode 23.11.2025 - 10.09.2026

Rincian metrik keuangan lan pasar Galmed Pharmaceuticals Ltd. (GLMD)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis wiwitan perusahaan:Galmed Pharmaceuticals Ltd
Produk dadi galmedpharma.com

This metric compares the total enterprise value to annual revenue, excluding the impact of debt load to determine the actual market value of one dollar of sales. By analyzing the EV/Sales multiple history, an investor can discern the efficiency of the mobile capital of Galmed Pharmaceuticals (GLMD), whose clinical research outsourcing strategy minimizes capital expenditures and directly reflects the purity of this valuation.